A humorous message about actor Tom Hanks at the closed Las Vegas Mini Grand Prix amid the coronavirus pandemic.
Ethan Miller/Getty Images
Precision medicine is often touted as the future of medicine. But so far, it hasn't been helpful in the war against COVID-19. Here is how it could be used to tease apart the nuances of the disease.
By Science Photo/Shutterstock
PODCAST: The first episode of a new series from The Anthill focuses on precision medicine.
Introducing a new series from The Anthill podcast on the future of personalisation in healthcare.
Statins are imprecise and rather brilliant.
Precision medicine is all the rage, but it may only be effective at treating less common diseases.
The first personalised medicine trial for a nutritional supplement has just reported its results.
Clinical trials are important, but can’t get us to medicine prescribing that is 100% effective.
Image Point Fr/Shutterstock.com
Clinical trials are used to establish that medicines work. But these don't take into account the genetic differences between us that can mean very different outcomes for different patients.
Decoding all the DNA in a patient’s biological sample can reveal whether an infectious microbe is causing the disease.
Superfast DNA analysis is now being used to crack medical mysteries when physicians can't figure out whether an infectious microbe is causing the disease.
Rapidly advancing technologies, including artificial intelligence, robotics, 3D-printing, smart-phones, smart-homes, precision medicine and diagnostics, promise to disrupt health care as we know it.
In an era of rapid technological advance, devastating climate change, increasing inequality and a steadily aging society, health-care leadership development is vital.
Research published in Science Translational Medicine in February 2019 used a virtual patient to test the drug, Fevipiprant.
Asthma affects around 339 million people worldwide. A new drug promises to lower risks of asthma attack and may eventually allow patients to reduce their dependence on steroids.
Identification of genetic mutations has led to the development of effective drugs.
"Precision medicine" is allowing us to analyse a person's genetic makeup and target treatments based on their specific needs.
More knowledge about your genetic makeup enables you to make better-informed choices – but at what cost?
It's exciting to think we're on the brink of a genomic revolution in health care. But just because new technology becomes available, it doesn't mean it should automatically be publicly funded.
Scientists discovered some bacteria can cut the DNA of invading viruses as a defence mechanism. They realised they could use this to cut human DNA.
CRISPR harnesses the natural defence mechanisms of some bacteria to cut human DNA strands. Then the DNA strand either heals itself or we inject new DNA to mend the gap. This is gene editing.
In 2030, some diseases are defined more specifically than in the past with a focus on their molecular makeup. This is known as precision medicine.
In 2030, there is a boom in precision medicine, where diseases – from cancer to dementia – are defined and targeted more specifically with a focus on their molecular makeup.
Though not this obvious from the outside, plants are keeping time.
Precisely calibrated timekeepers are found in organisms from all domains of life. Biologists are studying how they influence plant/pathogen interactions – what they learn could lead to human medicines.
If we could test the genome of all Australians we could better target preventive health campaigns.
If you could take a test that would reveal the diseases you and your family might be more likely to get, would you want to do it?
Precision medicine matches patients with interventions, rather than just matching treatments to illnesses.
People with the same condition can respond differently to the same treatment. This is why personalised treatment is so important in all fields of medicine, including psychology.
If you were destined for dementia in your 60s, but there was nothing you could do about it, would you want to know?
A test of all your genes for disease risk is not yet the precision diagnostic and treatment tool we hope it will one day be.
A tumor under the microscope.
Cropped from cnicholsonpath/flickr
Cancer researchers dream of offering personalized treatments to patients. Can they get there using the same math that drives Netflix recommendations?
Cancer precision targeting at the Systems Biology and Cancer Metabolism Laboratory. Credit: Systems Biology and Cancer Metabolism Laboratory.
Fabian V. Filipp
A field called epigenomics looks at chemical modifications that do not change our DNA sequence but can affect gene activity. What are the limitations, and can biomedicine use this to our advantage?
Tools of diabetes treatment almost always include improved diet and regular exercise.
Diabetes, which afflicts 29 million people in the U.S., remains a difficult disease to treat. Read how an algorithm devised by MIT researchers could help.